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Abstract
Rationale: Structural differences between ventricular regions may not be the sole determinant of local ventricular fibrillation
(VF) dynamics and molecular remodeling may play a role.
Objectives: To define regional ion channel expression in myopathic hearts compared to normal hearts, and correlate
expression to regional VF dynamics.
Methods and Results: High throughput real-time RT-PCR was used to quantify the expression patterns of 84 ion-channel,
calcium cycling, connexin and related gene transcripts from sites in the LV, septum, and RV in 8 patients undergoing
transplantation. An additional eight non-diseased donor human hearts served as controls. To relate local ion channel
expression change to VF dynamics localized VF mapping was performed on the explanted myopathic hearts right adjacent
to sampled regions. Compared to non-diseased ventricles, significant differences (p,0.05) were identified in the expression
of 23 genes in the myopathic LV and 32 genes in the myopathic RV. Within the myopathic hearts significant regional (LV vs
septum vs RV) expression differences were observed for 13 subunits: Nav1.1, Cx43, Ca3.1, Cava2d2, Cavb2, HCN2, Na/K
ATPase-1, CASQ1, CASQ2, RYR2, Kir2.3, Kir3.4, SUR2 (p,0.05). In a subset of genes we demonstrated differences in protein
expression between control and myopathic hearts, which were concordant with the mRNA expression profiles for these
genes. Variability in the expression of Cx43, hERG, Na+/K+ ATPase ß1 and Kir2.1 correlated to variability in local VF dynamics
(p,0.001). To better understand the contribution of multiple ion channel changes on VF frequency, simulations of a human
myocyte model were conducted. These simulations demonstrated the complex nature by which VF dynamics are regulated
when multi-channel changes are occurring simultaneously, compared to known linear relationships.
Conclusions: Ion channel expression profile in myopathic human hearts is significantly altered compared to normal hearts.
Multi-channel ion changes influence VF dynamic in a complex manner not predicted by known single channel linear
relationships.
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Introduction
The grave hemodynamic consequence of human ventricular
fibrillation (VF) limits its study in vivo. Cell cultures [1] and animal
models [2,3,4] have been utilized to test hypotheses regarding
ionic currents and the spatiotemporal organization of VF.
Although these models allow for elegant testing of the roles of
single ion channels or currents [5], remodeling in myopathic
human hearts involves multiple ion channels and requires a
different investigative strategy. Regional differences in VF
dynamics have mechanistic implications [2,6]. In guinea pig
hearts, a dominant high-frequency rotor in the left ventricle
maintains VF, and appears to depend on inter-compartmental
differences in IK1 [3]. Whether ion channel heterogeneity
correlates with regional VF dynamics in human hearts has not
been studied.
VF can be studied in explanted human hearts using a modified
Langendorff perfusion system [7,8]. This model provides the
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closest approximation to in-vivo VF in diseased hearts, allowing
detailed electrophysiological mapping [9]. Our previous analyses
in myopathic human hearts suggest that chamber-specific fibril-
lation dynamics are not entirely explained by regional structural
differences [10]. An alternate hypothesis is that regional hetero-
geneity of ion channel expression may contribute to variations in
VF dynamics. Regional transmural differences in the Ca2+ATPase
[11] and Connexin [12] proteins as it pertains to conduction
velocity and block with pacing in human hearts has been
evaluated. These studies involved the testing of a hypothesis
specific to a single factor in contribution to conduction in paced
wedge sections, however regional multichannel correlation to VF
in fibrillating whole human hearts has not been studied. We
previously detailed the regional and tissue specific transcript
signatures of ion channel genes in normal human hearts [13]. A
comprehensive region-specific transcriptional expression profile of
ion channels in myopathic human hearts and their potential
relevance to spatial organization during VF may provide insight
into potential therapeutic targets.
Therefore, we investigated comprehensive regional transcrip-
tional differences in cardiac ion channel subunits between
myopathic and non-diseased human hearts, and protein expres-
sion in a subset of important genes. We then tested the hypothesis
that regional heterogeneity of ion channel transcripts will correlate
with heterogeneity in local fibrillation dynamics.
Materials and Methods
The experimental protocol was approved by the University
Health Network ethics committee. Informed written consent was
obtained from each patient and appropriate forms and documen-
tation outlining the use of these myopathic human hearts and the
purpose of this research study was provided to each patient. The
University Health Network ethics committee approved the consent
procedure.
The experimental protocol was approved by the Ethical Review
Board of the Medical Center of the University of Szeged.
Informed written consent was obtained for the use of these non-
diseased human hearts in this research study.
All procedures conformed to the Helsinki Declaration of the
World Medical Association.
Myopathic Human Hearts
This experimental protocol was approved by the University
Health Network ethics committee, and informed consent was
obtained from each patient. Human cardiac tissue was dissected
from eight cardiomyopathic patients (2 women, 6 men) who
underwent cardiac transplantation. The mean age was 5369
years, all patients had ejection fractions ,20%. Immediately after
explantation, hearts were immersed in cold Tyrode solution, and
flushed thoroughly to remove blood particles. Left and right
ventricular (LV and RV) and septal samples (1 mm thick) were
dissected from the endocardial surfaces of the mid portion of the
heart and snap-frozen with liquid nitrogen. As the study sought to
determine the effects of myopathy induced ion channel remodel-
ing on VF dynamics, as opposed to structural architecture effects,
samples were taken from areas of healthy looking myocardium
distant to areas of visual and palpable scar. We have previously
demonstrated that ion channel activity is significantly different
within hearts between areas of abnormal and relatively normal
histology [14]. Summary of myopathic hearts used in the study are
found in Table 1.
Control Human Hearts
This experimental protocol was approved by the Ethical Review
Board of the Medical Center of the University of Szeged. Eight (2
women, 6 men) non-diseased human hearts (age 4568 years) were
explanted from organ donors to collect pulmonary and aortic
valves for transplant surgery. Tissue was collected and stored as
described for the myopathic hearts.
RNA preparation
Total RNA from each cardiac tissue was isolated and DNase-
treated with the RNeasy Fibrous Tissue Mini Kit (Qiagen). The
quality of total RNA was assessed by polyacrylamide-gel
microelectrophoresis (Agilent 2100 Bioanalyser). Lack of genomic
DNA contamination was verified by PCR.
TaqMan real-time reverse transcriptase-polymerase chain
reaction
The TaqMan Low-Density Array (TLDA, Applied Biosystems)
technology was used in a two-step reverse-transcriptase-polymer-
ase chain reaction process, as previously reported [13]. Briefly,
first-strand cDNA was synthesized from 2 mg of total RNA using
the High-Capacity cDNA Archive Kit (Applied Biosystems). PCR
reactions were then performed on TLDA with the ABI Prism
7900HT Sequence Detection System (Applied Biosystems). The
384 wells of each card were preloaded with 9664 predesigned
fluorogenic TaqMan probes and primers (Table S1). Probes were
labeled with the fluorescent reporter 6-carboxyfluorescein (FAM;
Appler Corp.) at the 59-end and with non-fluorescent quencher on
the 39-end. Data were collected with instrument spectral
compensation with Applied Biosystems SDS 2.1 software and
analyzed with the threshold cycle (Ct) relative-quantification
method. The genes selected for their cardiac expression encode
84 a- and b-ion channel subunits, Na+, K+-ATPase isoforms and
proteins involved in calcium homeostasis and four reference genes
for normalization.
For data normalization, we selected the Mean Ct [15] of the
most expressed genes (Ct,30) and shifted those to the average one
of HPRT. The mean Ct thus provides a reliable correction of the
experimental variability increasing the biological variation accu-
racy [15]. The relative expression level of each gene is indicated as
the 22DCt. In order to determine regional specific heterogeneity in
transcriptional expression in the myopathic human hearts, the
relative expression levels of each gene and for each region were
averaged and compared between LV, RV, and septum. Outliers
were elicited and removed from the mean of each group after a
Grubbs’ test was applied.
Protein extraction and Western-blot
Freshly-isolated left ventricular endocardial samples from
normal and myopathic hearts were fast-frozen in liquid nitrogen,
pulverized and homogenized in TNE-buffer containing: Tris 25-
mmol/L, EDTA 5-mmol/L, EGTA 5-mmol/L, NaCl 150-mmol/
L, NaF 20-mmol/L, Na3VO4 0.2-mmol/L, ß-glycerophosphate
20-mmol/L, AEBSF 0.1-mmol/L, leupeptin 25-mg/mL, aprotinin
10-mg/mL, pepstatin 1-mg/mL, microcystin-LR 1-mmol/L;
pH 7.34, HCl. Homogenized samples were centrifuged at
1,000 g for 10 minutes, supernatant collected and ultracentrifuged
at 100,000 g for 1 hour. The supernatant was resuspended and
incubated in TNE-buffer containing 1% Triton-X100. Protein
concentration was determined by Bradford assay (Biorad). All
steps were carried out on ice at 4–5uC. Protein samples (20 mg)
were separated on 8% poly-acrylamide SDS-PAGE and trans-
ferred electrophoretically onto PVDF membranes. The PVDF
Ion Channel Heterogeneity and VF Dynamics
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membranes were blocked in a PBS-solution containing 0.05% (v/
v) Tween-20 and 5% (w/v) nonfat dried milk (NDM) and
incubated overnight at 4uC with primary antibodies diluted in PBS
containing 0.05% Tween-20 and 1%-NDM. After washing with
PBS-Tween solution/1%-NDM, membranes were hybridized
with HRP-conjugated secondary antibody. Immunoreactive bands
were detected by enhanced chemiluminescence using BioMax
MS/MR films. Protein quantification was performed with the
Quantity OneH software (Biorad). All of the expression data are
provided relative to GAPDH staining for the same samples on the
same gels.
Antibodies
Primary antibodies (1/2000) included monoclonal mouse anti-
SERCA2 ATPase (2A7-A1; MA3-919), monoclonal mouse anti-
Phospholamban (2D12; MA3-922), polyclonal rabbit anti-Calse-
questrin (PA1-913) and monoclonal mouse anti-Na+,K+-ATPase
alpha-3 (XVIF9-G10; MA3-915) from Thermo scientific, mono-
clonal mouse anti-Kir2.2 (S24-1; ab84821) from Abcam, mono-
clonal mouse anti-Kir2.3 (N25/35; 75-069) from Neuromab, and
monoclonal anti-GAPDH (10R-G109a) from Fitzgerald. Peroxi-
dase-conjugated AffiniPure goat anti-rabbit IgG (111-035-144)
and Affinipure donkey anti-mouse IgG (715-035-151) from
Jackson ImmunoResearch were used as secondary antibodies (1/
10,000).
Human Langendorff- Cardiac Electrophysiology
After the samples were removed from the myopathic hearts the
coronary arteries were selectively cannulated and flushed thor-
oughly with Tyrode solution (composition: 118.1 mM NaCl,
4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4, 24.9 mM
NaHCO3, 1.2 mM KH2PO4, 6.1 mM glucose). The Tyrode was
oxygenated with a pediatric oxygenator connected to a carbogen
(95% O2, 5% Co2) cylinder. The flow was subsequently
maintained at 0.9 to 1.1 ml/g/min at 38uC, and the hearts were
placed in a heat-jacketed reservoir at 38uC. Electrical mapping
was performed on the epicardium using a custom sock array and
on the LV endocardium using a second balloon array as described
previously [16]. Due to the marked heterogeneity of VF over short
intra-ventricular distances, recordings were made from three
electrodes adjacent to tissue sampling locations, allowing local
electrophysiological correlation with local gene expression. VF was
induced within 20 minutes of cannulation by placing a 9-volt
battery on the epicardium. Bipolar electrograms were evaluated to
ensure appropriate contact. After data acquisition, all electrograms
were low-pass filtered at 60 Hz using a 112th order FIR equiripple
filter, and down-sampled to 125 Hz. For analysis, 20-second
segments of VF were included, from the septum, RV and LV free
walls.
Fibrillation Dynamics
To determine fibrillation dynamics right adjacent to the region
sampled we used the most robust of the near field VF dynamic.
Two local parameters of local fibrillation dynamics were assessed;
cycle length (activation rate) and conduction block. Local
activation rates were calculated using both unipolar and bipolar
electrograms at the local recording sites. Peak dV/dt in the
unipolar signal was used as a marker of local activation, which was
confirmed to coincide with the activation in the bipolar signal.
Local cycle length (interval between activations) was measured
over 5 seconds and the values averaged to estimate the cycle
length for that region. To estimate spatial organization we used
double peak incidence (DPI) as described by Evans et al. [17]
Double spectral peaks have been shown to be an indicator of
conduction block. We computed the fraction of total time the DPI
were present in an electrogram and averaged it over 3 electrodes
in a region to get the mean fraction of time the DPI was present
per VF episode.
Regional comparison of transcripts
Analysis of variance was used to compare mean values between
myopathic and normal heart ventricular transcript expression,
both LV and RV comparisons. Comparisons of gene expression
between ventricular regions were conducted within sets of samples
from individual patients, thus controlling for inter-individual
variability. Comparisons of gene expression within myopathic
heart chambers (LV vs RV vs Septum) was performed with a
general linear model, each gene entered as a dependent variable,
region entered as the fixed factor, and individual heart identifi-
cation included in the model. Corrections using LSD were used for
paired comparisons. Significance was evaluated for P,0.05.
Correlating ion-channel transcriptional profiling to
electrophysiological measures
Local transcriptomal profiling was correlated to VF parameters
by regression analysis. To limit the number of variables entered in
regression analysis, we entered only genes that are functionally
important in the heart (34/84). The independent predictors of VF
Table 1. Isolated Human Hearts Clinical Data.
# Sex (M/F) Age (Yrs) Diagnosis EF (%)
LV Dimensions Diastolic/
Systolic (mm) Medication prior to explant
1 F 48 ICM ,20 60/48 Digoxin, Spironolactone, Aspirin
2 M 60 ICM ,20 59/48 Furosemide, Metolazone, K-Dur, Ramipril
3 M 57 ICM 21 73/64 Carvedilol, Candesartan, Hydralazine
4 M 63 IDCM ,20 57/39 Metoprolol, Omeprazole, Sildenafil, Coumadin
5 F 47 IDCM ,20 78/64 Citalopram, Furosemide
6 M 61 ICM 13 78/73 Pravastatin, Furosemide, Glyburide, Aspirin
7 M 50 VCM 20 69/51 Digoxin, Aldactone, Ranitidine
8 M 36 ARVC 19 71/60 Sotalol, Amiodarone, Ramipril
IDCM - Idiopathic dilated Cardiomyopathy; ICM - Ischemic Cardiomyopathy; VCM – Valvular Cardiomyopathy; ARVC – Arrhtyhmogenic Right Ventricular
Cardiomyopathy.
doi:10.1371/journal.pone.0082179.t001
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cycle length and conduction block (DPI) were determined by
multiple regression including stepwise selection. The independent
variables were entered one at a time in the order in which they
most improved the model R2. The alpha level for retention of a
variable in the model was 0.15.
Computer Simulations
Computer simulations were performed using the ten Tusscher
human epicardial ventricular ionic model [PMID:16565318] as a
basis. Myopathic versions for the left and right ventricles were
created by modifying the simulation parameters of the model
according to protein expressions levels (Table 2). Monodomain
simulations on a 1265 cm sheet with sealed edges were carried out
using the CARP simulator [PMID:14716595]. The temporal
discretization used was 25 microseconds while the spatial dis-
cretization was set at 150 micrometers. A stable rotor was created,
using the unmodified ionic model, by applying an S1 along the left
edge of the tissue and applying an S2, which, covered the lower left
quarter of the sheet. The rotor was allowed to stabilize and the
state saved after 1.5 seconds, which became the initial conditions
for all subsequent simulations. Modifications were made to the
ionic model and then the activity was continued for another four
seconds. All rotors persisted for this length of time. The average
dominant frequency of these four seconds of activity was
determined by taking discrete Fourier transforms of each node
in the model, selecting the frequency associated with the highest
energy component, and then averaging these frequencies over the
whole sheet.
Results
Clinical characteristics
Table 1 summarizes clinical characteristics of myopathic heart
patients.
Ion channel transcript signatures in myopathic human
hearts compared to normal human hearts
Expression levels for the myopathic hearts and normal hearts
were compared by ventricular chamber. The genes showing
significant differences (p,0.05) in expression are presented for the
LV (Tables 3 and 4) and RV (Tables 5 and 6). The expression
profile of all genes analyzed in this study can be found in Table S2.
Calcium handling proteins. In the myopathic ventricles the
expression of SERCA2 and its regulatory protein PLN were
significantly reduced compared to the normal hearts. Expression
of the sarcoplasmic reticulum (SR) Ca binding protein calseques-
trin was significantly increased in both myopathic ventricles.
Calcium Channel subunits. In the myopathic LV, expres-
sion levels of the a1 subunit Cav3.2 and the a2d subunit Cava2d1
were higher than control LVs. In the myopathic RVs expression of
Cava2d1 was higher than controls.
Exchangers. In the myopathic LV and RV the expression of
Na+/K+ ATPase a3 was significantly reduced compared to the
normal cohort.
Sodium Channel subunits and Connexins. Expression for
Nav1.3, Nav2, and Navb2 was significantly higher in the LV of the
myopathic hearts compared to normal hearts, while, in the
myopathic RV, expression was higher for Nav1.3 and Navb2, and
lower for Nav1.7 than controls. No significant difference was
observed for Cx40, Cx43, or Cx45 transcript expression for either
ventricle between the myopathic and normal hearts.
Table 2. Relative changes in ionic model parameters
compared to published normal values.
Parameter LV myopathic RV myopathic
Cx43 0.8 1.15
IKr 0.55 0.6
NaK 0.66 0.8
IK1 1.64 1.6
NCX 1 1.2
SERCA 0.5 0.5
CASQ 1.25 1.4
doi:10.1371/journal.pone.0082179.t002
Table 3. Comparison of Na+, Cl2 and Ca2+ channel subunits,
Ca2+ handling proteins and exchanger expression levels
between myopathic and normal LV’s.
Subunit Normal Myopathic P-value
Nav1.3 3.5160.78 6.8061.02 0.022
Nav2 220.88622.41 380.50653.26 0.015
Navb2 33.4068.42 74.8163.48 ,0.001
Cav3.2 3.4960.26 8.0861.51 0.010
Cava2d1 159.86615.38 236.21615.84 0.004
CFTR 2.2760.64 0.1560.04 0.015
Na/K ATPase a3 1599.526146.13 1128.90670.86 0.012
Na/K ATPase b1 1119.32674.20 836.58630.03 0.003
SERCA2 4635.356333.73 2214.786160.50 ,0.001
PLN 16292.3761380.77 8658.846460.77 ,0.001
CASQ2 2108.07690.71 2671.546121.65 0.002
Units for all values are 22DCt versus reference gene (6100), expressed as mean
6 SEM. Only expression comparisons achieving p,0.05 are presented.
doi:10.1371/journal.pone.0082179.t003
Table 4. Comparison of K+ channel subunit expression levels
between myopathic and normal LV’s.
Subunit Normal Myopathic P-Value
Kv1.4 11.6461.82 21.1961.20 0.001
Kv1.5 12.5561.18 17.9961.63 0.017
Kv1.7 5.4061.27 0.8160.22 0.033
Kv3.4 10.6661.19 17.2361.36 0.003
Kv4.3 26.7261.60 16.3060.91 ,0.001
Kv11.1/HERG 191.23617.96 105.6865.08 ,0.001
Kir2.2 74.6268.69 46.4262.16 0.007
Kir2.3 80.89610.26 132.44612.81 0.007
Kir3.4 37.0465.87 10.1762.01 0.001
Kvb1 9.5361.53 19.1961.87 0.001
KCHIP2 222.26633.29 47.73611.61 ,0.001
SUR1 4.1160.49 7.9261.66 0.045
Units for all values are 22DCt versus reference gene (6100), expressed as mean
6 SEM. Only expression comparisons achieving p,0.05 are presented.
doi:10.1371/journal.pone.0082179.t004
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Potassium channel subunits. Transcripts responsible for
transient inward current Ito were altered in an inconsistent pattern
in the myopathic hearts. In the LV, Kv1.7 and Kv4.3 expression
was reduced, while Kv3.4 expression was increased. In the RV
Kv1.4 expression was increased, while expression of Kv1.7 and
Kv4.3 was decreased. Transcripts responsible for the inward
rectifying current IK1, Kir2.1 and Kir2.2, showed differing
expression profiles between LV and RV when compared to the
normal ventricles. Kir2.2 was significantly decreased in both LV
and RV, while Kir2.1was significantly upregulated in the RV. The
expression of Kir3.4 transcripts, which contribute towards the
production of the inward rectifying current IkACh, was significantly
weaker in the myopathic ventricles than the normal ventricles.
The a- (Kir6.1 and Kir6.2) and ß-subunits (SUR1 and SUR2)
responsible for the production of IkATP were also analyzed. Of
these subunits SUR1 showed increased expression in both
myopathic ventricles, while the Kir6.2 showed decreased expres-
sion in myopathic RV when compared to normal ventricles.
Regional ion channel transcript profile in myopathic
human hearts
We compared expression between the LV, RV and septum
within the 8 myopathic hearts. Figures 1–3 show paired
comparisons between chambers for the transcripts that demon-
strate significant difference, p,0.05 (Figure 1 LV vs RV; Figure 2
LV vs septum; Figure 3 RV vs septum).
Calcium channels and calcium handling
proteins. Expression of Cav3.1 was significantly higher in the
RV compared to the septum and LV. RyR expression was much
higher in the RV than the LV. Calsequestrin expression was
significantly higher in the septum. The expression of the Cavß2
showed higher levels of expression within the RV compared to the
LV, while the Cava2d2 was higher in the septum compared to
both the LV and RV.
Sodium, chloride, connexins and pumps. The expression
of Cx43 was greater in the RV than the LV or the septum.
Expression of Na+/K+ ATPase a3 was greater in the RV than the
LV and septum.
Potassium channels. Kir2.3 (Ik1) expression was significant-
ly greater in the LV and septum compared to the RV. Kir3.4
(IkACh) expression was significantly stronger in the septum
compared to the LV. Expression for the pacemaker channel
HCN2 was much stronger in the LV than the RV. SUR2
expression was significantly higher in the RV compared to the
septum.
Transcriptomal Correlation to VF Heterogeneity
Mean VF cycle length was 313 ms (LV=239 ms;
RV=384 ms; Septum=308 ms, p =NS). Fraction of time DPI
was present was in average 25.7% (LV=31.4%; RV=20.2%;
Septum=25.4%. p=NS). Figure 4 demonstrates the local VF
unipolar electrogram recordings and examples of local activation
rate and spectral analysis. The results of the regression analysis are
presented in Table 7. Amongst the 34 transcripts analyzed,
variability in Cx43, hERG, Na+/K+ ATPase b1 and Kir2.1
expression correlated with variability in VF cycle length (p,
0.001). Cx43, Kir2.1 had a positive slope, indicating increasing
expression levels contributed to increasing cycle length, while
hERG and Na+/K+ ATPase b1 had a negative slope, indicating
increasing expression levels correlated with decreasing cycle
length. Of the 34 transcripts in the model, variability in Cx45,
Kir3.1, Cx43, SUR2, and Kir2.3 correlated with variability in
conduction block (DPI) incidence during VF. Kir3.1, Kir2.3 and
SUR2 had a positive slope, indicating increasing expression levels
correlate with increasing conduction block, while Cx45and Cx43
had a negative slope, indicating that increasing expression levels
correlate with decreasing conduction block.
Table 5. Comparison of Na+, Cl2 and Ca2+ channel subunits,
Ca2+ handling proteins and exchanger expression levels
between myopathic and normal RV’s.
Subunit Normal Myopathic P-Value
Nav1.3 3.8460.89 6.7360.67 0.013
Nav1.7 6.5660.67 4.0460.42 0.007
Navb2 27.0066.45 61.7764.40 0.001
Cava2d1 131.4868.85 216.61614.74 ,0.001
CIC-7 93.32613.89 53.1663.85 0.015
CFTR 2.4860.53 0.3260.14 0.005
HCN3 4.4360.67 2.7560.21 0.031
HCN4 73.0569.05 43.0867.48 0.023
Na/K ATPase a3 1769.95697.85 1277.98691.14 0.002
NCX1 625.55649.09 762.10625.93 0.028
SERCA2 4827.016306.21 2863.626253.89 ,0.001
SERCA3 15.9261.48 11.3261.42 0.042
PLN 14969.1162155.61 9954.706593.50 0.042
CASQ2 2032.56684.64 2809.946170.95 0.001
ITPR1 76.1165.92 55.3664.40 0.014
Units for all values are 22DCt versus reference gene (6100), expressed as mean
6 SEM. Only expression comparisons achieving p,0.05 are presented.
doi:10.1371/journal.pone.0082179.t005
Table 6. Comparison of K+ channel subunit expression levels
between myopathic and normal RV’s.
Subunit Normal Myopathic P-Value
Kv1.4 8.4360.87 20.3562.32 ,0.001
Kv1.7 5.7761.25 0.6960.33 0.002
Kv3.3 2.1860.24 1.5260.16 0.038
Kv4.3 26.0761.73 18.1761.62 0.005
Kv11.1/HERG 195.47614.86 115.5563.47 ,0.001
KvLQT1 91.4763.23 63.0163.23 0.001
TWIK-1 80.9368.82 52.6467.18 0.026
Kir2.1 95.99612.98 169.16629.44 0.004
Kir2.2 90.2369.83 53.1262.47 0.039
Kir2.3 46.4866.30 84.1568.27 0.003
Kir3.4 20.90613.92 12.3262.22 0.036
Kir6.2 41.4466.10 27.2662.26 0.047
Kvb1 10.6661.04 16.9161.50 0.004
KCHIP2 320.57622.74 119.68625.22 ,0.001
TASK2 2.2760.47 0.9760.18 0.021
MinK 11.8060.99 16.8261.83 0.003
SUR1 3.8460.84 8.2661.57 0.026
Units for all values are 22DCt versus reference gene (6100), expressed as mean
6 SEM. Only expression comparisons achieving p,0.05 are presented.
doi:10.1371/journal.pone.0082179.t006
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Protein analysis
We determined the protein expression levels for a subset of
genes with Western blot analysis of freshly isolated LV endocardial
tissue from control and myopathic hearts (Figure 5). Of the genes
that were analyzed, SERCA2, PLB, CASQ2 and Na+/K+ATPase
a3 (Figure 5A–D) demonstrated differences in protein expression
between control and myopathic hearts, which were concordant
with the mRNA expression profiles for these genes. For each of the
genes, protein expression was significantly reduced in myopathic
hearts when compared to controls, with the exception of PLB,
which was not significantly different but did show a decreasing
trend. In the case of Kir2.2, protein expression levels are elevated
in myopathic hearts versus controls (Figure 5E), in contrast to the
mRNA expression profile of this channel. In the case of Kir2.3 no
significant difference was observed between myopathic and control
LV endocardium (Figure 5F). The discordance between the
protein and mRNA expression profiles for Kir2.2 and Kir2.3 may
be attributed to translational and post-translational regulation
specific processes.
Figure 1. Significant (p,0.05) differences in gene expression levels between LV and RV samples within myopathic hearts.
Differentially expressed genes in LV versus RV. Units for all expression values are 22DCt versus reference gene (6100). Only expressions comparisons
achieving p,0.05 are depicted.
doi:10.1371/journal.pone.0082179.g001
Figure 2. Significant (p,0.05) differences in gene expression levels between LV and septal samples within myopathic hearts.
Differentially expressed genes in LV versus septum. Units for all expression values are 22DCt versus reference gene (6100). Only expressions
comparisons achieving p,0.05 are depicted.
doi:10.1371/journal.pone.0082179.g002
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Computer simulations
Using the ventricular myocyte model described in the methods
section, we manipulated only the parameters of the model which
were associated with frequency changes to see their effect in
isolation and in combination with each other, using protein
expression levels derived from our study (Table 2). Thus, NCX,
CASQ, and SERCA were set differently for LV and RV
myopathic tissue but were not varied to see their effect on
frequency. The modeling experiments yielded a stable rotor and
subsequently parameters were manipulated to determine the
effects on VF frequency. Starting with the protein levels for one
ventricle, either myopathic LV or RV, the four parameters were
systematically changed to those of the other ventricle. The results
of these simulations are summarized as circular data plots
(Figure 6).
The circular plots represent the changes in rotor frequency after
manipulation of four different molecular components: Cx43,
hERG, Na+/K+ ATPase ß1 and Kir2.1. Within the data plots, red
indicates an increase and blue a decrease in cycle frequency, with
color intensity corresponding to the degree of change. Examining
the plots radially from the inner to outer circles illustrates the
contribution of each molecular component to cycle frequency as
the number of components changed was increased. The only
component, which showed a consistent response across all
changes, was IK1, which was associated with an increase in
frequency when it was decreased in the LV, regardless of the other
parameters changed. However, increasing IK1 in the myopathic
RV was not always associated with a decrease in frequency. In the
RV, decreasing Cx43 and IKr individually increased frequency,
but combined, decreased frequency. These results indicate that the
Cx43 and IKr act as molecular components that most likely alter
frequency by two different mechanisms, and together the two
channels have antagonistic effects on frequency. Furthermore, if
the system was simply linear, the two plots would be complements
of each other, i.e., increasing a parameter leading to an increase of
frequency in one ventricle would lead to a decrease in frequency
when the parameter is decreased in the other ventricle, resulting in
blue and red being exchanged between the two plots. However,
this is not the case since additional parameters were different in the
RV and LV, which were not changed. Specifically, NCX and
CASQ were slightly different. In the LV, the largest decrease was
seen with changes in Cx43 and NaK, which corresponds to the
largest frequency increase seen in the RV. However, the largest
frequency increase in the LV, changing IK1 and IKr, did not
correspond to the largest frequency decrease in the RV. The
results of our computer simulations illustrate the complexity of
determinants regulating cycle frequency. Since frequency was
averaged over an area, factors, which affected it, included the
absolute refractory period, the propensity for block, tissue
dimensions, and the size and movement of the rotor core. The
core region was important since the core itself did not demonstrate
action potentials, serving to decrease average frequency. In the
RV, the maximum frequency observed over the tissue was
decreased for only one case (NaK2,IK1+) yet average frequencies
either increased and decreased. An increase in both the minimum
and maximum frequencies was observed when Cx43, NaK and
IK1 were changed in the RV but an overall decrease in frequency
was observed. Thus, global behavior could not be predicted by
changes in one single characteristic.
Figure 3. Significant (p,0.05) differences in gene expression levels between RV and septal samples within myopathic hearts.
Differentially expressed genes in RV versus septum. Units for all expression values are 22DCt versus reference gene (6100). Only expressions
comparisons achieving p,0.05 are depicted.
doi:10.1371/journal.pone.0082179.g003
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Discussion
In this study the comprehensive regional ion channel transcript
profile in failing human hearts was compared to normal hearts and
demonstrated significant differences in multiple transcripts. As a
practical strategy, in a subset of genes we studied the protein
expression levels with Western blot analysis of LV endocardial
tissue from control and myopathic hearts. This analysis demon-
strated differences in protein expression between control and
myopathic hearts, which were concordant with the mRNA
expression profiles for the genes studied. The regional differences
in transcript expression were correlated to functional electrophys-
iological parameters during ventricular fibrillation and through
use of statistical model we suggest that a limited number ion
channels correlate with the heterogeneity in regional fibrillation
dynamics, and may serve as targets for future studies for
modulation of human VF in myopathic human hearts.
Expression Signatures in Myopathic Hearts
Previous studies using microarrays for transcriptomal profiling
have examined gene expression differences across cardiac regions
in various models [18,19,20,21]. The current study is confirmatory
and expands these findings in humans by comparing gene
expression within and between myopathic and non-diseased
hearts. Further, our study differs by specifically focusing on ion
channels, connexin, calcium cycling and related subunits. In
comparison to these previous studies, our findings demonstrate
several significant differences likely the result of the different
experimental procedures and sources for tissue sampling, as well as
methods and technology (TLDA) utilized. Finally, our study helps
provide correlations between the various genes analyzed and the
possible role they may play, thereby providing novel substrates for
further investigation.
Reductions in the transient outward current Ito during phase 1
of the cardiac action potential prolongs action potential duration
and may be proarrhythmic [22]. In the myopathic LV and RV we
report significant down regulation in the subunit largely respon-
sible for the fast phase of Ito (Ito,f, Kv4.3), and dysregulation of
subunits which contribute to the slow phase of Ito (Ito,s, qKv1.4,
QKv1.7). The reduction in Ito,f not only prolongs action potential
duration but adversely modulates excitation-contraction coupling
by affecting L-type Ca2+ magnitude [23]. Multiple animal studies
Figure 4. Regional VF Mapping and determination of local activation rate and conduction block. Local unipolar recordings of VF are
displayed from the LV and RV. For the LV recording unipolar activation is marked (maximal negative dV/dt) demonstrating local activation rate and
cycle length. The FFT of the RV recording shows 2 peaks indicating local conduction block. The bottom panels show the determinants of conduction
block (left) and cycle length (right) in the order they entered the regression models.
doi:10.1371/journal.pone.0082179.g004
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have demonstrated a reduction in the Ik1 current in the myopathic
state, and related Ik1 to VF [3,5,24,25,26]. In our model Kir 2.2
was reduced in both myopathic ventricles when compared to
normal. While IkACh plays a significant role in the response to
vagal input and atrial fibrillation the role in human ventricular
myopathy is unclear [27]. Our findings demonstrated a significant
reduction in both LV and RV myopathic ventricles for Kir3.4
transcripts. Kir3.4 subunits form a heteromeric assembly with
Kir3.1 subunits, which leads to the production of IkACh in both
Table 7. Results of regression analysis for predictors of VF cycle length and conduction block (DPI) incidence.
Stepwise Multiple Regression (for predicting Cycle Length and incidence of Conduction Block)
Model R2 Regression Coefficient p-Value
Predictor Variables* (For Cycle Length)
Cx43 0.57 0.415 ,0.001
Na+/K+ ATPase b1 0.79 20.428 0.090
Kir2.1 0.86 8.82 0.044
hERG 0.95 27.95 0.004
Predictor Variables** (For Conduction Block)
Cx45 0.41 20.59 0.001
Kir3.1 0.63 2.24 0.068
Cx43 0.72 20.03 0.006
SUR2 0.79 0.0197 0.014
Kir2.3 0.88 0.19 0.049
Stepwise multiple regression analysis was performed to evaluate the contribution of ion channels to Cycle length or incidence of conduction block. Expression level of
each ion channel was added to the regression model and those with significant contribution to dependent variables were retained in the model. Data presented in the
table demonstrates the most appropriate fit, capable of predicting the incidence of CL and conduction block.
*Among all ion channels assessed, expression of Cx43, Na/K ATPase b1, Kir2.1 and hERG were the most significant predictors of Cycle length.
**Among all ion channels assessed, expression of Cx45, Kir3.1, Cx43, SUR2 and Kir2.3 significantly correlated with incidence of conduction block.
doi:10.1371/journal.pone.0082179.t007
Figure 5. Comparison of protein expression in LV sample from control and cardiomyopathic patients. A: Top; representative SERCA2
and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom; Mean6SEM, *** P,0.001. B: Top; representative
phospholamban (PLB) and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom; Mean6SEM, P = 0.051. C: Top;
representative calsequestrin 2 (CSQ) and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom; Mean6SEM, * P,
0.05. D: Top; representative Na/K-ATPase-a3 and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom;
Mean6SEM, *** P,0.001. E: Top; representative Kir2.2 and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom;
Mean6SEM, * P,0.05. F: Top; representative Kir2.3 and respective GAPDH stainings obtained in normal and cardiomyopathic LV samples. Bottom;
Mean6SEM. n = 8 control LV samples, n = 6 cardiomyopathic LV samples.
doi:10.1371/journal.pone.0082179.g005
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ventricles, the dysregulation of Kir3.4 and its association with
myopathy warrants further investigation.
Heart failure causes defective Ca2+ sequestration into the
sarcoplasmic reticulum due to a reduction in the expression of
SERCA2, which leads to reduced amplitude and slowed decay of
the intracellular Ca transient [28]. Consistent with previous
studies, the expression of SERCA2 was significantly lower in the
myopathic compared to the normal ventricles. Slower kinetics of
Ca2+ reuptake by the sarcoplasmic reticulum can result in an
increased propensity for T-wave alternans and early after-
depolarisations that are proarrhythmic [29]. Although there was
no significant difference in RyR2 expression between the
myopathic and normal hearts, the expression was much lower in
the myopathic LV compared to the myopathic RV. Compart-
mental reduction of SERCA2 and RyR2 expression may
contribute to arrhythmia heterogeneity with the LV being at
greater risk of arrhythmia initiation on the basis of spontaneous
calcium leak compared to RV ectopy. Expression of the SR
calcium storage protein, calsequestrin was significantly increased
in the myopathic compared to normal hearts. Increased
calsequestrin is predicted to increase Ca2+ storage capacity of
the sarcoplasmic reticulum; however, release of Ca2+ by the SR
may be decreased [30]. While the physiological response of
increased calsequestrin expression in myopathic human hearts has
not been described, over expression of calsequestrin leads to
hypertrophy and decreased contractility in mice [31]. Our findings
provide further evidence into the potential influential role
SERCA2 and RyR2 may play in VF maintenance. While these
findings do not provide definitive conclusions it yields information,
which warrant future investigation and study.
As it would be impractical to perform protein analysis of all 84
genes studied in the transcriptomal analysis, we performed
selective Western blot analysis of important genes to verify that
the comparison of normal to myopathic was indeed valid. Our
protein analysis indicated that the transcriptome analysis was
effective at assessing which gene products were up- or downreg-
ulated between normal and myopathic hearts. As such, provides
additional support to the correlative relationships between gene
expression and VF dynamics we set forth in our study.
Transcriptomal profile and VF Dynamics
Animal studies have linked alteration of specific ionic currents,
particularly Ik1, with VF dynamics [3,5,24,25,26]. However, this
paradigm was established in models where single channels/
currents were considered. With the exception of specific primary
arrhythmic disorders such as Brugada and long QT syndromes,
disturbances in cardiac conduction and repolarisation in myo-
pathic hearts are generally the result of altered expression of
multiple ion channels and gap junction subunits [32,33]. The
alteration of one channel leads to compensatory mechanisms
affecting other channels, and remodeling in disease states likely
produces specific expression signatures involving the pantheon of
ion channels. Though alterations of single channel provides for
rigorous hypothesis testing, in the clinical myopathic state where
there are changes to multiple ion channels the determinants of VF
dynamics becomes more complex. The transcriptomal methodol-
ogy used in this study allows portraits of global expression to be
created from small samples while allowing detailed near real-time
electrophysiological measurements in arrhythmia. This combined
approach is critical to understanding the physiological and clinical
importance of regional expression variations, which promote
arrhythmogenesis in the whole organ. While our transcriptomal
approach allows us to only make correlations between the genes
analyzed in this study and their potential electrophysiological
implications, it provides a framework to provide further under-
standing into the complex mechanism of arrhythmogenesis.
While our study primarily focused on characterizing the
transcriptomal profile of myopathic and normal hearts, we
attempted to make further correlations between specific genes
identified in our analysis with VF generation. The correlative
model we constructed suggests ion channel transcript expressional
variability correlates to regional differences in electrophysiological
parameters observed during VF. The role of Ik1 in local VF
dynamics is complex and has a varying role depending how far it is
from the core of the rotor [34]. Despite this complexity, expression
level of Kir2.1 and Kir2.3 were significant determinants of VF
dynamics in the regression models. In murine monolayers
heterogeneity of Kir2.1 expression has been demonstrated to
contribute to the genesis and stability of spiral waves [5]. Thus
Figure 6. Computer simulations. Effect of protein level changes on average frequency. Starting with the left (A) or right (B) ventricular myopathic
ionic model, parameters were changed to match expression levels in the other ventricle as specified in Table 2. Increases in frequency are red while
decreases are blue, with brighter colors indicating more change from control. Each ring represents a simulation with each quarter circle representing
a parameter change. If the parameter was altered for the simulation, it is colored coded according to the resultant frequency change, otherwise it is
left as grey. Frequencies range from 4.71–4.99 Hz with a baseline frequency of 4.83 Hz for the LV and 4.76 Hz for the RV.
doi:10.1371/journal.pone.0082179.g006
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local heterogeneity of Kir2.1 is a critical component of VF
dynamics and may be more important than absolute levels in
determining local cycle lengths. It has been elegantly shown that
greater Ik1 expression allows for rapidity of rotational speed of
rotors, as such our finding of a positive correlation with cycle
length may appear contradictory. It is, however, important to note
that the findings of Dr. Jalife relates to the highest frequency found
at a particular point [34], and not the average over the region.
The findings of Ik1 expression allowing for rapidity of rotational
speed is applicable if we had removed myocardial samples at the
rotor anchor points in all samples we analyzed, which is unlikely. It
is most likely that we sampled away from the rotor. The distance
from the rotor has an impact on whether this expression would
have an increasing or decreasing effect on cycle length [34]. It has
been also shown that the rectification and resting membrane
potential have a significant effect on the influence of Ik1 on VF
dynamics and may be pertinent to our apparent contradictory
findings, especially in the myopathic hearts, where the resting
membrane potential is altered [35]. To better understand the
contribution of multiple ion channels changes that occur
simultaneously, on VF frequency we modified the parameters of
four molecular components: Cx43, hERG, Na+/K+ ATPase ß1
and Kir2.1. These components contribute to factors, which
regulate rotor core movement, refractory period and conduction
block. In our computer simulation average rotor frequencies
calculated under the various simulations demonstrates that IK1
may play a role in either increasing or decreasing rotor frequency
depending on its interplay with other channels. In the LV,
decreasingIK1 was shown to consistently increase average VF
frequency regardless of the contribution from any of the other
channels, consistent with this study. However, the minimum and
maximum frequencies observed within the tissue were decreased,
keeping in line with reported effects of IK1 block on VF frequency
[34].The response of changing IK1 in the RV was much more
variable. While our regression model provided an insight into the
role of ion channel changes on VF dynamics in human
cardiomyopathy, our computer simulations provide evidence
demonstrating the complex nature of how VF dynamics are
regulated in opposite directions predicted by known linear
relationships of single ion channel changes depending on the
interplay of other determinants.
As expected, increasing expression of Na+/K+ ATPase ß1
resulted in faster conduction velocity and shorter VF cycle lengths.
Increased hERG (Ikr) resulted in decreased cycle length, possibly
by increasing conduction velocity as a result of shortening
repolarization time. In our model, the most significant predictor
of VF cycle length at each of the three sites was the level of Cx43
expression. Surprisingly increased expression of Cx43 resulted in
an increase in cycle length. Though this study cannot establish the
mechanistic rationale, this may suggest the regions studied have
provided pivot points for reentry and thus have registered higher
activation in regions with decreased Cx43 expression, as a result of
spatial heterogeneity [36,37,38]. Alternatively, altered post-trans-
lational modification of Cx43 (hypophosphorylation and lateral-
ization of gap junctions) in heart failure may alter gap junction
electrotonic influences on activation rates. An increase in Cx45 or
Cx43 resulted in decreased conduction block. Increases in either
connexin subunit alters the Cx45:Cx43 ratio reducing gap
junctional inter-cellular communication which may result in
increased conduction block. However, increases in homomeric
homotypic Cx43 and Cx45 gap junctions may reduce functional
conduction block by improving inter-cellular conduction. Overall
our findings signifying the importance of connexin subunits in
regulation of VF dynamics are in concordance with findings from
the Efimov group [12]. They demonstrated the significance of
Cx43 expression in regulating conduction velocity in ventricular
wedge preparations from human hearts with end-stage nonisch-
emic cardiomyopathy. The downregulation of Cx43 in addition to
reduction in protein phosphorylation were identified as critical
components in generation of arrhythmogenic states in those with
nonischemic cardiomyopathy. Increasing SUR2 (IkATP) was also a
determinant of VF dynamics, perhaps by action potential duration
modulation due to global ischaemia that ensues during VF and
activation of these channels shortening repolarization duration.
Our group has published the importance of KATP subunit gene
expression in cardiomyopathic human hearts [39]. We demon-
strated heterogenous expression pattern of Kir6.1, Kir6.2, SUR1
and SUR2A throughout the left ventricle. Additionally, we showed
that KATP channel blockade led to the promotion of spontaneous
defibrillation in cardiomyopathic human hearts by attenuating the
ischemia-dependent spatiotemporal heterogeneity of refractoriness
during early VF [39]. Interestingly the gene expression data of our
current study preceded the findings of our work with the KATP
channel subunits. As such, the identification of genes in this
present study and the strong correlative relationship characterized
through our statistical model provides promise for the use of our
shotgun approach in the further identification of ion channel
variation which may play a key contributory role in VF dynamics.
Limitations
In this study, we examined alterations in mRNA expression
levels of various ion channel transcripts in the septum, RV and
LV. There is no mRNA-based assay that provides information on
mRNA stability, posttranslational processes, or subunit assembly.
Therefore, mRNA transcript levels may not correspond directly to
channel activity. The goal of this study was to utilize a shot-gun
gene analysis approach to identify as many potentially novel
molecular targets involved in VF dynamics, such that future ion
channel specific studies can be formulated with the channels
identified. While we acknowledge that definitive correlations on
VF dynamics cannot be made unless channel activity can be
isolated for all 84 ion channels studies, it nevertheless provides a
compilation of potential targets, which will be the focus of future
studies. These studies will be focused on individual molecular
targets identified within this study and will include cell isolation
and patch clamp experiments. Local VF cycle length and
conduction block is also determined by local myocardial architec-
ture, particularly the amount of scar/fibrosis. Our previous study
of VF dynamics evaluating the role of anatomic structure
suggested that regional VF dynamics are only partially explained
by such differences [10]. As such, the focus of this study was to
determine the spatial gene expression profile of ion channel
subunits in normal compared to myopathic tissue samples, and to
then use this data in combination with regression analysis to
generate correlations which could be used to yield insight into the
molecular determinants which may contribute to VF dynamics.
Samples were taken from areas of visually and palpably healthy
myocardium in order to isolate ion channel remodeling effects,
from local fibrosis, on VF dynamics. Additionally, we were not
able to fully eliminate the possibility of contamination by purkinje
fibers in our isolated endocardial biopsies. Finally, we acknowledge
the heterogeneity of the myopathic hearts used in this study. The
different disease states among the myopathic hearts may lead to
undetermined differences in ion channel expression and VF
dynamics which were not examined separately in this study.
To study fibrillation dynamics, we used VFCL as a surrogate for
refractoriness during VF as previously published (28). In this study
we did not specifically evaluate regional electrical remodeling as
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measured by APD and CV and its relationship to VF dynamics.
This was the basis of detailed studies conducted by Nanthakumar
et al [2,40]. In those studies of an in-vivo model of VF, using 1008
electrodes with 2 mm resolution, regional electrical properties
were related to regional DF, activation maps, excitable gap and
reentry. However in that study, the influence of regional molecular
characteristics to regional VF dynamics was not performed and
was the basis of the design of this study.
Conclusions
Ion channel expression profile in myopathic human hearts is
significantly altered compared to normal hearts and reveals
regional differences. The correlative relationships between several
specific genes with VF dynamics and the modeling studies indicate
a complex interactive influence on cycle length and conduction
block. Our study provides an expression profile of molecular
targets, which may contribute to VF within myopathic hearts.
Using regression analysis and computer simulations we have
uncovered complex interactions of key ion channel determinants
of VF dynamics that could provide novel substrates for safe
therapeutic strategies.
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